Longeveron (LGVN) Earnings Date & Reports

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LGVN is expected to report earnings to fall 36.76% to -21 cents per share on May 10

Q1'24

Est.

$-0.22

Q1'25

Missed

by $0.13

Q4'24

Missed

by $0.07

Q4'23

Missed

by $0.81

Q3'23

Missed

by $0.05

The last earnings report on May 08 showed earnings per share of -34 cents, missing the estimate of -20 cents. With 219.76K shares outstanding, the current market capitalization sits at 19.81M.

View a ticker or compare two or three

Compare

Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)

Annualized Return+9%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

LGVN